메뉴 건너뛰기




Volumn 83, Issue 8, 1998, Pages 2635-2642

Clinical and economic impact of implementing a comprehensive diabetes management program in managed care

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; DIABETES MELLITUS; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MANAGED CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0031786677     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2635     Document Type: Article
Times cited : (126)

References (20)
  • 2
    • 2642626655 scopus 로고    scopus 로고
    • Economic consequences of diabetes mellitus in the U.S. in 1997
    • American Diabetes Association. 1998 Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 21:296-309.
    • (1998) Diabetes Care , vol.21 , pp. 296-309
  • 3
    • 0031897103 scopus 로고    scopus 로고
    • Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults, the third national health and nutrition examination survey, 1988-1994
    • Harris MI, Flegal KM, Cowie CC, et al. 1998 Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults, the third national health and nutrition examination survey, 1988-1994. Diabetes Care. 21:518-524.
    • (1998) Diabetes Care , vol.21 , pp. 518-524
    • Harris, M.I.1    Flegal, K.M.2    Cowie, C.C.3
  • 4
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:977-986.
    • (1993) N Engl J Med. , vol.329 , pp. 977-986
  • 5
    • 0028940198 scopus 로고
    • Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group. 1995 Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol. 75:894-903.
    • (1995) Am J Cardiol. , vol.75 , pp. 894-903
  • 6
    • 0000330524 scopus 로고
    • Why the DCCT applies to NIDDM patients. American Association of Clinical Endocrinologists: AACE Guidelines for Management of Diabetes Mellitus
    • Davidson M. 1994 Why the DCCT applies to NIDDM patients. American Association of Clinical Endocrinologists: AACE Guidelines for Management of Diabetes Mellitus. Clin Diabetes. 12:141-144.
    • (1994) Clin Diabetes , vol.12 , pp. 141-144
    • Davidson, M.1
  • 7
    • 0028877313 scopus 로고
    • Resource utilization and costs of care in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group. 1995 Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care. 18:1468-1478.
    • (1995) Diabetes Care , vol.18 , pp. 1468-1478
  • 8
    • 0029908290 scopus 로고    scopus 로고
    • Life-time benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group. 1996 Life-time benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 276:1409-1415.
    • (1996) JAMA , vol.276 , pp. 1409-1415
  • 10
    • 0029952531 scopus 로고    scopus 로고
    • Changing behavior: Practical lessons from the DCCT
    • Lorenz RA, Bubb J, Davis D, et al. 1996 Changing behavior: practical lessons from the DCCT. Diabetes Care. 19:648-652.
    • (1996) Diabetes Care , vol.19 , pp. 648-652
    • Lorenz, R.A.1    Bubb, J.2    Davis, D.3
  • 11
    • 15444344568 scopus 로고    scopus 로고
    • Big changes for diabetes disease management: Is your MCO missing the boat?
    • American Health Consultants. 1998 Big changes for diabetes disease management: is your MCO missing the boat? Disease State Management. 4:13-24.
    • (1998) Disease State Management , vol.4 , pp. 13-24
  • 12
    • 15444356860 scopus 로고    scopus 로고
    • Clinical Practice Recommendations 1998
    • American Diabetes Association. 1998 Clinical Practice Recommendations 1998. Diabetes Care. 20(S1).
    • (1998) Diabetes Care , vol.20 , Issue.S1
  • 13
    • 0004288052 scopus 로고    scopus 로고
    • Washington, DC: National Committee for Quality Assurance
    • National Committee for Quality Assurance. 1997 Health Plan Employer Data and Information Set (HEDIS). Washington, DC: National Committee for Quality Assurance.
    • (1997) Health Plan Employer Data and Information Set (HEDIS)
  • 14
    • 0029165804 scopus 로고
    • Physician and patient prevention practices in NIDDM in a large urban managed care organization
    • Martin TL, Selby JV, Zhang D. 1995 Physician and patient prevention practices in NIDDM in a large urban managed care organization. Diabetes Care. 18:1124-1132.
    • (1995) Diabetes Care , vol.18 , pp. 1124-1132
    • Martin, T.L.1    Selby, J.V.2    Zhang, D.3
  • 15
    • 0030764041 scopus 로고    scopus 로고
    • Excess costs of medical care for patients with diabetes in a managed care population
    • Selby JV, Ray TG, Zhang D, Colby C. 1997 Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 20:1396-1402.
    • (1997) Diabetes Care , vol.20 , pp. 1396-1402
    • Selby, J.V.1    Ray, T.G.2    Zhang, D.3    Colby, C.4
  • 16
    • 0032484999 scopus 로고    scopus 로고
    • The pills that ate your profits
    • Meyer H. 1998 The pills that ate your profits. Hosp Health Netw. 72(3):18-22.
    • (1998) Hosp Health Netw. , vol.72 , Issue.3 , pp. 18-22
    • Meyer, H.1
  • 17
    • 0031910689 scopus 로고    scopus 로고
    • Projecting future drug expenditures-1998
    • Mehl B, Santell JP. 1998 Projecting future drug expenditures-1998. Am J Health Syst Pharm. 55:127-136.
    • (1998) Am J Health Syst Pharm. , vol.55 , pp. 127-136
    • Mehl, B.1    Santell, J.P.2
  • 18
    • 15444346214 scopus 로고    scopus 로고
    • Model of complications of NIDDM: I. Model construction and assumptions
    • Eastman RC, Javitt JC, Herman WH, et al. 1997 Model of complications of NIDDM: I. Model construction and assumptions. Diabetes Care. 20:725-733.
    • (1997) Diabetes Care , vol.20 , pp. 725-733
    • Eastman, R.C.1    Javitt, J.C.2    Herman, W.H.3
  • 19
    • 15644366137 scopus 로고    scopus 로고
    • Model of complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
    • Eastman RC, Javitt JC, Herman WH, et al. 1997 Model of complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care. 20:735-744.
    • (1997) Diabetes Care , vol.20 , pp. 735-744
    • Eastman, R.C.1    Javitt, J.C.2    Herman, W.H.3
  • 20
    • 0002358012 scopus 로고    scopus 로고
    • Preliminary results of a disease management program for diabetes
    • Ginsberg BH. 1996 Preliminary results of a disease management program for diabetes. JCOM. 3:45-52.
    • (1996) JCOM , vol.3 , pp. 45-52
    • Ginsberg, B.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.